ASFA Celebrates Apheresis Awareness Day

Posted in :: 2020 Volume 7 :: Thursday, September 17th, 2020

On September 15, 2020, the American Society for Apheresis (ASFA) celebrated Apheresis Awareness Day. The purpose for this observance is to raise awareness of apheresis medicine, including apheresis practitioners and the donors and patients they save every day using evidence-based practice.

The awareness day included an official hashtag (#ApheresisDay2020), online games including Jeopardy and Apheresis Word Scramble, and a Question of the Day.

We at FACT extend our heartfelt appreciation to apheresis professionals around the world, including physicians, nurses, technicians, scientists, quality managers, and more who work as an important team performing life-saving work every day. We acknowledge the extensive role they play both in providing standard of care therapy and cutting edge research. Apheresis professionals are in high demand because the work they do is so important. Thank you for all that you do!


SAVE THE DATE: FACT Announces Virtual Inspection & Accreditation Workshop

Posted in :: 2020 Volume 5 :: Wednesday, July 29th, 2020


Canceled: FACT Cellular Therapy Collection Inspection and Accreditation Workshop

Posted in :: 2020 Volume 3 :: Friday, April 24th, 2020

The American Society for Apheresis (ASFA) Board of Directors has decided not to proceed with the ASFA 2020 Annual Meeting, originally scheduled for May 6 – 9, 2020 in Austin, Texas due to the coronavirus (COVID-19) outbreak.

For the same considerations, the associated FACT Cellular Therapy Collection Inspection and Accreditation Workshop scheduled for May 6, 2020 has also been cancelled.

The ASFA Board of Directors is currently assessing the feasibility of rescheduling the Annual Meeting for later this year. If ASFA reschedules the annual meeting, the FACT workshop will also be rescheduled. Your payment will be applied to the new FACT Collection Inspection and Accreditation Workshop date. If the meeting is not rescheduled for 2020, your payment can be applied to the FACT workshop at the 2021 ASFA Meeting. If you prefer to receive a refund, please contact the FACT Business Manager, Jay Ann Witt at jawitt@unmc.edu.

The health and well-being of our cellular therapy community, volunteers, staff, and patients is our utmost concern. We look forward to seeing you at our next workshop. If you have questions, please do not hesitate to contact the FACT Office.


ASFA Releases Updated Practice Guidelines for Therapeutic Apheresis

Posted in :: 2019 Volume 6 :: Thursday, June 13th, 2019

The Special Issue Writing Committee of the American Society for Apheresis (ASFA) updated indications for evidence-based use of therapeutic apheresis (TA). The Guidelines on the Use of Therapeutic Apheresis in Clinical Practice  – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue contains fact sheets summarizing the evidence for the use of TA for 84 relevant diseases and medical conditions.

Fact sheets related to blood and marrow transplantation included in these guidelines include graft-versus-host disease (GVHD), ABO-incompatible hematopoietic stem cell transplantation, and HLA-desensitized hematopoietic stem cell transplantation. Given the wide range of TA performed by apheresis facilities, review of all fact sheets is worthwhile.

Padmanabhan, A, Connelly‐Smith, L, Aqui, N, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019; 34: 171– 354. https://doi.org/10.1002/jca.21705


Announcing New FACT Board Members

Posted in :: 2019 Volume 1 :: Wednesday, January 16th, 2019

The Foundation for the Accreditation of Cellular Therapy (FACT) is pleased to announce the addition of three new members to the Board of Directors: Alan Balch, Patrick Hanley, and Nadim Mahmud. The Board provides leadership for carrying out FACT’s mission to improve the quality of cellular therapy through peer-developed standards, education and accreditation for the benefit of patients.

FACT Chief Executive Officer, Linda Miller, announced, “I am pleased to welcome our three newest members to our Board of Directors. They each have a unique background, with diverse experiences that make them an asset to FACT’s Board of Directors and to the organization as a whole.”

Alan Balch, PhD is the Chief Executive Officer of the Patient Advocate Foundation and National Patient Advocate Foundation. Dr. Balch will serve as FACT’s Public Director.

Dr. Balch has nearly fifteen years of executive leadership in the non-profit sector with an emphasis on consensus-building and collaboration. He has led numerous federal advocacy efforts on a range of issues both at the legislative and regulatory level over the years. He became the CEO of both PAF and NPAF in 2013. From 2006 – 2013, he served as the Vice President of the Preventive Health Partnership — a national health promotion collaboration between the American Cancer Society, American Diabetes Association, and American Heart Association. He has led numerous federal advocacy efforts at the legislative and regulatory level including  organizing  and  leading a  coalition  that  successfully  fought  for improvements in the regulatory process for the review of cancer drugs at the Food and Drug Administration.  He also contributed to the development of key federal policies related to the Affordable Care Act.

Patrick Hanley, PhD is an assistant research professor of pediatrics in the Center for Cancer and Immunology research at the Children’s Research Institute, a member of the Division of Blood and Marrow Transplantation, and a member of the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System. Dr. Hanley will serve as the chair of FACT’s Education Committee.

Dr. Hanley is the director of the Good Manufacturing Practices (GMP) facility where novel cell therapies developed in the Program for Cell Enhancement and Technologies for Immunotherapy (CETI) are translated and manufactured for early stage clinical trials. In addition to GMP regulations, Dr. Hanley is interested in helping to improve outcomes after stem cell transplantation – including bone marrow transplant and cord blood transplant. Along with the CETI director, Dr. Catherine Bollard, he has pioneered work in expanding virus-specific immune cells from naïve T cells, such as those present in cord blood or virus-seronegative donors. Dr. Hanley is the co-chair of the Early Stage Professionals group of the International Society for Cellular Therapy and a member of the Immunotherapy scientific committee and is interested in making cell therapies standard-of-care.

Nadim Mahmud, MD, PhD is currently serving as Professor of Medicine and Bioengineering at the University of Illinois College of Medicine at Chicago. He also serves as the Director of the Clinical Stem Cell Laboratory for the University of Illinois Hospital (UI Health) Blood and Marrow Transplant Program. Dr. Mahmud leads FACT’s international initiatives as Chair of the Global Affairs Committee.

Dr. Mahmud has more than 20 years of research experience in the field of hematopoietic stem cell biology and transplantation. Dr. Mahmud and his group have pioneered a novel way to expand the number of transplantable blood forming stem cells present in an umbilical cord blood graft by using chromatin modifying agents and have been awarded a US patent for this work.
In addition, Dr. Mahmud serves as member of the Board of Directors of the International Society for Cell and Gene Therapy (ISCT).

2019 FACT Board of Directors

 Appreciation to Outgoing Board Members

The board meeting during the American Society for Hematology (ASH) conference in December was the final for departing board members. Although they are leaving the board, we will definitely be relying on their knowledge and skills moving forward. The following people have completed their terms on the board:

Ian McNiece, PhD who has served on the board for nine years as a director has served as chair of the Regenerative Medicine Task Force. His leadership has led to the development of accreditation for cell processing facilities performing more than minimal manipulation; the publication of the first edition FACT Common Standards for Cellular Therapies; initiation of the development of Cardiovascular Cell Therapy Standards; and launched the Regenerative Medicine InterCHANGE to share lessons learned from recent advancements in cell therapy with other stakeholders in the field.

Catherine Bollard, MBChB, MD who has served on the board for nine years as a director has served as chair of the Professional Relations Committee. Dr. Bollard’s charge for this committee was to enhance communication, cooperation, and scientific advancement with each of the following organizations: ISCT, ASBMT, WBMT/NETCORD, ASFA, FACT, NMDP, AABB, CAP, ASHI, ASGCT, and CBA. Dr. Bollard led the discussions for information sharing between organizations resulting in identification of collaborative opportunities, reduction in redundant efforts, and creation of alliances for more impactful results.


Education Events

Posted in :: 2018 Volume 1 :: Thursday, February 15th, 2018

FACT Cellular Therapy Inspection & Accreditation Workshop
Tuesday, February 20, 2018
Salt Lake City, UT

The blood and marrow transplant field has been a leader in voluntarily improving quality, and accredited Clinical Programs are currently adapting to several new FACT Standards and procedural changes to the accreditation process. This workshop will provide background on these changes. The morning workshop sessions include major topics such as how to effectively transition to the 7th Edition Hematopoietic Cellular Therapy Standards, CIBMTR data audits, clinical outcomes including center reported causes of low survival, and the accreditation of immune effector cellular therapy programs.

The afternoon session includes two different tracks: New Inspector Training Orientation and Common Citations. The Inspector Training track includes sessions on the FACT accreditation process, what documents to review before an inspection, the ins and outs of performing an onsite inspection, how to conduct an exit interview, and finally, how to make your case via the inspection report. The Common Citations track will review recent deficiencies and corrections related to commonly cited Standards in the areas of quality management, personnel, and donor information and consent to donate. Sessions are accompanied by exercises and group discussions to practically apply lecture concepts to real-world experiences.

Note: Inspector trainees are required to attend the New Inspector Training Orientation Track.

View meeting details and register online

Cellular Therapy Leadership Course at BMT Tandem – 101
Tuesday, February 20, 2018
Salt Lake City, UT 

Do you want to improve your leadership skills? Everyone wins when leaders get better, and this half-day course is designed for that outcome.

In years past, participation in FACT’s leadership workshop has been by invitation. The course is open to anyone who has (or aspires to) a leadership position in cell therapy – whether you direct a transplant center or laboratory, lead a cell collection service or cord blood bank, head a staff of nurses or transplant coordinators, hold an office or board position in a volunteer organization, chair a committee, or have any position in which you are expected to motivate and lead a team

The highly interactive and participatory curriculum teaches leadership principles including:

• The leader as coach
• Differences between managing and leading
• Basic styles of leadership and how to recognize your own style
• When each style of leadership may be appropriate
• Running and participating in effective meetings
• How to build consensus
• Four proven ways to motivate people
• Effective delegation skills
• How to adapt to change, and even be a change agent
• Understanding and exercising governance roles and responsibilities

Woven throughout the leadership course is an overview of FACT’s organizational structure, purpose, challenges, current programs and accomplishments.

Whatever you lead, this course is designed to help you recognize your leadership skills and acquire new ones that effectively encourage innovation, achieve consensus, build momentum, turn ideas into reality, eliminate distractions and guide a team toward goals.

View meeting details and register online  

Cellular Therapy Advanced Leadership Course at BMT Tandem – 201
Tuesday, February 20, 2018 
Salt Lake City, UT

If you completed FACT’s Cell Therapy Leadership 101 course in a previous year and want more, the 201 course is for you.

This advanced workshop drills deeper into organizational development and leadership skills. Topics include:

• Characteristics of a healthy organization
• Adapting an organization to a changing environment
• Multiplying and diminishing the effectiveness of a team
• Leading from where you are
• Servant leadership
• Effective governing boards
• Legal implications of decision-making and liability and fiduciary responsibilities
• Strategic planning with a focus on outcomes

Participants in the prerequisite Cell Therapy Leadership 101 course in the morning also are eligible to register for the 201 course in the afternoon.

Registration is free for current inspectors and approved inspector trainees. Physicians wishing to train to become an inspector for the FACT Immune Effector Cell Accreditation Program must meet prerequisite education and experience requirements, submit a satisfactory inspector application, attend an in-person training workshop, view online videos, and complete a test on the requirements. To apply to become an inspector, submit an online application.

View meeting details and register online

FACT-ASBMT Quality Boot Camp
Wednesday, February 21, 2018
Salt Lake City, UT

Join us for the FACT-ASBMT Quality Boot Camp at the 2018 BMT Tandem Meetings on February 21 in Salt Lake City, Utah.  This year’s boot camp will focus on topics identified to be challenging by transplant programs complying with FACT requirements. The boot camp will strengthen your quality assurance activities through an in-person workshop. Members of the FACT Quality Committee and the ASBMT Administrative Directors SIG Quality Working Group encourage you in the months leading up to the BMT Tandem Meetings to review your quality program and identify strengths and weaknesses.

View meeting details and register online

Effectively Transition to the 7th Edition Hematopoietic Cellular Therapy Standards
Wednesday, March 14, 2018
Webinar

This presentation will be on Wednesday, March 14, 2018, at 11:00 am ET. Paul Eldridge, PhD, Director of Cell GMP Facility at UNC Bone Marrow Transplant and Cellular Therapy Program, will describe changes to the 7th edition Standards and provide examples for effective implementation.

View meeting details and register online

WMDA-NetCord Webinar: Manual and Automated Methods for Thawing of Cord Blood
Wednesday, March 21, 2018
Webinar

This WMDA-NetCord webinar is March 21, 2018, at 11:00 ET. Cellular therapy departments must thaw cord blood units, and they often use very different processes from the procedures outlined by the cord blood bank providing the unit. These SOPs are sent by the cord blood bank and are not always adapted to the disposals and reagents used by the department who then thaw the units. Diane Fournier, PhD, of Héma-Québec, and Roger Horton, PhD, of The Anthony Nolan Cord Blood Bank, will discuss manual and automatic thawing methods used by different departments for thawing of these units, and what can be done to improve recovery of the cells. Also, a multi-center study for harmonization of post thaw analysis of CD34 and CD45 cells will be presented.

View meeting details and register online

Cellular Therapy Collection Workshop at ASFA Annual Meeting
Wednesday, April 25, 2018
Chicago, IL

This training workshop is designed to explain the requirements for FACT accreditation of cellular therapy programs, with special emphasis on apheresis collection facilities. FACT representatives will be in attendance to clarify the intent of the FACT-JACIE Standards, provide inspectors tips for conducting inspections, and assist programs in organizing and preparing for the accreditation process.

View meeting details and register online

Cellular Therapy Inspection & Accreditation Workshop
Tuesday, May 1, 2018
Montreal, Quebec Canada

This training workshop is designed to explain the requirements for FACT accreditation of cellular therapy programs. FACT representatives will be in attendance to clarify the intent of the FACT-JACIE Standards, provide inspectors tips for conducting inspections, and assist programs in organizing and preparing for the accreditation process.

The afternoon session will include two different tracks (TBA). All sessions are accompanied by exercises and group discussions to practically apply lecture concepts to real-world experiences.

View meeting details and register online

Cord Blood Inspection and Accreditation Workshop
Friday, September 14, 2018
Miami, FL

This training workshop is designed to explain the requirements for FACT accreditation of cord blood banks. FACT representatives will be in attendance to clarify the intent of the NetCord-FACT Standards, provide inspectors tips for conducting inspections, and assist programs in organizing and preparing for the accreditation process.

Would you like to attend the workshop for FREE? Apply to be a FACT inspector. If you are approved, you can attend free of charge!

View meeting details and register online

 

 


Upcoming Educational Events

Posted in :: 2017 Volume 2 :: Thursday, October 26th, 2017

FACT Immune Effector Cellular Therapy Inspection and Accreditation Workshop at SITC Annual Meeting
Thursday, November 9, 2017
National Harbor, MD
This training workshop is designed to educate participants on two key perspectives: building quality into their immune effector cell programs and performing peer-based inspections. FACT’s mission is to improve the quality of cellular therapy programs and depends on volunteer experts to visit programs and assess their compliance with the Standards. This peer-review approach keeps FACT accreditation credible, relevant, and useful. Attendees will learn about the mission of FACT, principles of FACT Standards, the accreditation process, and basic inspection techniques.

Registration is free for current inspectors and approved inspector trainees. Physicians wishing to train to become an inspector for the FACT Immune Effector Cell Accreditation Program must meet prerequisite education and experience requirements, submit a satisfactory inspector application, attend an in-person training workshop, view online videos, and complete a test on the requirements. To apply to become an inspector, submit an online application.

View meeting details and register online

WMDA-NetCord Webinar: Manual and Automated Methods for Thawing of Cord Blood
Wednesday, November 29, 2017
Webinar

This WMDA-NetCord webinar is November 29, 2017, at 11:00 ET. Cellular therapy departments must thaw cord blood units, and they often use very different processes from the procedures outlined by the cord blood bank providing the unit. These SOPs are sent by the cord blood bank and are not always adapted to the disposals and reagents used by the department who then thaw the units. Diane Fournier, PhD, of Héma-Québec, and Roger Horton, PhD, of The Anthony Nolan Cord Blood Bank, will discuss manual and automatic thawing methods used by different departments for thawing of these units, and what can be done to improve recovery of the cells. Also, a multi-center study for harmonization of post thaw analysis of CD34 and CD45 cells will be presented.

View meeting details and register online

FACT Immune Effector Cellular Therapy Inspection and Accreditation Workshop at ASH Annual Meeting
Friday, December 8, 2017
Atlanta, GA

This training workshop is designed to educate participants on two key perspectives: building quality into their immune effector cell programs and performing peer-based inspections. FACT’s mission is to improve the quality of cellular therapy programs and depends on volunteer experts to visit programs and assess their compliance with the Standards. This peer-review approach keeps FACT accreditation credible, relevant, and useful. Attendees will learn about the mission of FACT, principles of FACT Standards, the accreditation process, and basic inspection techniques.

Registration is free for current inspectors and approved inspector trainees. Physicians wishing to train to become an inspector for the FACT Immune Effector Cell Accreditation Program must meet prerequisite education and experience requirements, submit a satisfactory inspector application, attend an in-person training workshop, view online videos, and complete a test on the requirements. To apply to become an inspector, submit an online application.

View meeting details and register online

WMDA-NetCord Webinar: Cord Blood Outcome Data: How to Get it and How to Use it
Wednesday, December 13, 2017
Webinar

This webinar is December 13, 2017, at 10:00 ET. It is often difficult for cord blood banks to obtain outcome data following administration. Gesine Koegler, PhD, of the José Carreras Cord Blood Bank in Düsseldorf, and Andrea Darrow, Quality Manager at Cryo-Cell International, will discuss how to get and how to use cord blood outcome data. What have banks done that work well? And, once the information is received, how can it be used?

View meeting details and register online

QM Series 8: Staff Involvement in Document Control: Where do YOU fit in?
Wednesday, January 10, 2018
Webinar

This webinar is January 10, 2018, at 11:00 am ET. Mary Ann Kelley, DFCI, Associate Director of Quality Assurance CMCF at Dana Farber Cancer Institute / Cell Manipulation Core Facility, will discuss how staff is critical in the document control process, including developing, revising, reviewing, training, and accessing records. It will include information about protocols, and how to give staff access if programs rely on protocols instead of programmatic SOPs. This is the second webinar in the QM Series, Module 8.

View meeting details and register online

Applying the FACT Cord Blood Standards in Private Banking
Wednesday, January 17, 2018
Webinar

This webinar is January 17, 2018, at 9:00 AM ET. Elisabeth Semple, PhD, Cord Blood Bank Director at Cells for Life Cord Blood Institute Inc., Arvin Faundo, MD, Cord Blood Bank Director at Cordlife Group Limited, and Alexander Platz, MD, Cord Blood Bank Director at DKMS Cord Blood Bank, will discuss how family cord blood banks can comply with the NetCord-FACT 6th Edition Cord Blood Standards, methods to overcome challenges, and the benefits to achieving FACT accreditation.

View meeting details and register online

QM Series 8: The Digital Age: Controlling Documents within an Electronic System
Wednesday, January 24, 2018
Webinar

This presentation is Wednesday, January 24, 2018, at 11:00 am ET. Rebecca Maddox, Compliance Coordinator at Mayo Clinic Florida, will discuss the following:

  • The advantages and disadvantages of using a system,
  • How to incorporate an electronic system into your program,
  • Considerations to take into account when evaluating systems,
  • How to assess a system for compliance with the FACT Standards, and
  • What works well with her electronic system and what surprises she encountered.

View meeting details and register online

WMDA-NetCord Webinar: Informed Consent
Wednesday, February 7, 2018
Webinar

This presentation is Wednesday, February 7, at 11:00 am ET, 4:00 pm GMT. Daniel Gibson, Bsc (Hons), LIBMS, and Linda Moss, RM, of Anthony Nolan Cell Therapy Centre, will thoroughly review the different methods banks use to obtain informed consent, and the pros and cons of each method.

View meeting details and register online

FACT Cellular Therapy Inspection and Accreditation Workshop
BMT Tandem Meetings
Tuesday, February 20, 2018
Salt Lake City, UT

The blood and marrow transplant field has been a leader in voluntarily improving quality, and accredited Clinical Programs are currently adapting to several new FACT Standards and procedural changes to the accreditation process. This workshop will provide background on these changes. The morning workshop sessions include major topics such as how to effectively transition to the 7th Edition Hematopoietic Cellular Therapy Standards, CIBMTR data audits, clinical outcomes including center reported causes of low survival, and the accreditation of immune effector cellular therapy programs.

The afternoon session includes two different tracks: New Inspector Training Orientation and Common Citations. The Inspector Training track includes sessions on the FACT accreditation process, what documents to review before an inspection, the ins and outs of performing an onsite inspection, how to conduct an exit interview, and finally, how to make your case via the inspection report. The Common Citations track will review recent deficiencies and corrections related to commonly cited Standards in the areas of quality management, personnel, and donor information and consent to donate. Sessions are accompanied by exercises and group discussions to practically apply lecture concepts to real-world experiences.

Note: Inspector trainees are required to attend the New Inspector Training Orientation Track.

View meeting details and register online

Cellular Therapy Leadership Course at BMT Tandem – 101
Tuesday, February 20, 2018, 8:00 am – 12:00 pm
Salt Lake City, UT

Do you want to improve your leadership skills? Everyone wins when leaders get better, and this half-day course is designed for that outcome.

In years past, participation in FACT’s leadership workshop has been by invitation. The course is open to anyone who has (or aspires to) a leadership position in cell therapy – whether you direct a transplant center or laboratory, lead a cell collection service or cord blood bank, head a staff of nurses or transplant coordinators, hold an office or board position in a volunteer organization, chair a committee, or have any position in which you are expected to motivate and lead a team.

The highly interactive and participatory curriculum teaches leadership principles including:

  • The leader as coach
  • Differences between managing and leading
  • Basic styles of leadership and how to recognize your own style
  • When each style of leadership may be appropriate
  • Running and participating in effective meetings
  • How to build consensus
  • Four proven ways to motivate people
  • Effective delegation skills
  • How to adapt to change, and even be a change agent
  • Understanding and exercising governance roles and responsibilities

Woven throughout the leadership course is an overview of FACT’s organizational structure, purpose, challenges, current programs and accomplishments.

Whatever you lead, this course is designed to help you recognize your leadership skills and acquire new ones that effectively encourage innovation, achieve consensus, build momentum, turn ideas into reality, eliminate distractions and guide a team toward goals.

View meeting details and register online

Advanced Cellular Therapy Leadership Course at BMT Tandem – 201
Tuesday, February 20, 2018, 1:15 pm – 4:30 pm
Salt Lake City, UT

If you completed FACT’s Cell Therapy Leadership 101 course and want more, the 201 course is for you.

This advanced workshop drills deeper into organizational development and leadership skills. Topics include:

  • Characteristics of a healthy organization
  • Adapting an organization to a changing environment
  • Multiplying and diminishing the effectiveness of a team
  • Leading from where you are
  • Servant leadership
  • Effective governing boards
  • Legal implications of decision-making and liability and fiduciary responsibilities
  • Strategic planning with a focus on outcomes

Participants in the prerequisite Cell Therapy Leadership 101 course in the morning also are eligible to register for the 201 course in the afternoon.

View meeting details and register online

Cellular Therapy Collection Workshop at ASFA Annual Meeting
Wednesday, April 25, 2018
Chicago, IL

This training workshop is designed to explain the requirements for FACT accreditation of cellular therapy programs, with special emphasis on apheresis collection facilities. FACT representatives will be in attendance to clarify the intent of the FACT-JACIE Standards, provide inspectors tips for conducting inspections, and assist programs in organizing and preparing for the accreditation process.

View meeting details and register online

 

Cellular Therapy Inspection and Accreditation Workshop at ISCT Annual Meeting
Tuesday, May 1, 2018
Montreal, Quebec, Canada

This training workshop is designed to explain the requirements for FACT accreditation of cellular therapy programs. FACT representatives will be in attendance to clarify the intent of the FACT-JACIE Standards, provide inspectors tips for conducting inspections, and assist programs in organizing and preparing for the accreditation process.

The afternoon session will include two different tracks (to be arranged). All sessions are accompanied by exercises and group discussions to practically apply lecture concepts to real-world experiences.

View meeting details and register online


Qualification in Apheresis (QIA) Credential Now Available

Posted in :: 2016 Volume I :: Thursday, April 14th, 2016

The American Society for Apheresis (ASFA), in collaboration with the American Society for Clinical Pathology (ASCP), now offers a new credential in apheresis medicine.

The Qualification in Apheresis (QIA) is offered through ASCP and follows the Hemapheresis Practitioner (HP) and Apheresis Technician (AT) certifications. QIA certification expands credentialing for apheresis medicine professionals. There are specific eligibility routes that must be satisfied, including an eligibility route for international professionals.

The 50-question exam covers six areas: Basic Science; Clinical Applications; Donor/Patient Care; Instrumentation; Operational Considerations; and Standards, Guidelines, and Regulations. The qualification is valid for three years, and requalification requires participation in continuing education.

For more information on eligibility routes and available resources, visit the Qualification in Apheresis (QIA) page on the ASFA website.